Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey

Abstract

Warfarin is an anticoagulant medication that is challenging to manage. Dabigatran has been approved by the FDA for stroke and systemic embolism prevention in non-valvular atrial fibrillation as an alternative to warfarin. Dabigatran does not require routine monitoring, has an established dose, and lacks many of the drug, herbal, and food interactions that… (More)
DOI: 10.1007/s11239-013-0976-y

3 Figures and Tables

Topics

  • Presentations referencing similar topics